Medical University Of Vienna — Sponsor Intelligence | 83 EU Trials

Filter these 83 trials by condition, phase, country and more.

Open in Search →

83 Registered trials

57 Recruiting

12 Completed trials

12 Countries active

119 Unique IMPs

100% Results reported

Phase II

Phase IV

Phase I (Other)

Phase III: 4 Phase II: 29 Phase I/II: 2 Phase III/IV: 3 Phase IV: 22 Phase I: 4 Phase I (Other): 19

100%

12 of 12 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Antidepressant therapy 2 Anhedonia 2 Ejection fraction normal 1 Polymyalgia rheumatica 1 Sinus rhythm 1 Acute graft versus host disease in skin 1 Aortic disorder 1 Dermatomyositis 1 Negative symptoms in schizophrenia 1 Schizoaffective disorder depressive type 1 Antisynthetase syndrome 1 Immune-mediated myositis 1

Top IMPs

DUPILUMAB 4 CEFAZOLIN 3 ESKETAMINE HYDROCHLORIDE 3 LANDIOLOL HYDROCHLORIDE 3 PROPOFOL 3 SODIUM CHLORIDE 3 AMPICILLIN SODIUM 2 BEVACIZUMAB 2 CEFUROXIME SODIUM 2 GENTAMICIN 2 GOZETOTIDE 2 HEPARIN SODIUM 2

All trials — page 4

83 total

Meningococcal B vaccine in patients with asplenia Ended

2023-508192-36-00 Phase II 1 country RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. CO…
A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab toge… Ended

2024-513459-34-00 Phase I/II 1 country REGTIVEX; TOCILIZUMAB
Effect of Dupilumab on nasal epithelial barrier function in patients with Chronic Rhinosinusitis with nasal polyps (CRSwNP) – an exploratory… Ended

2023-509815-10-00 Phase IV 1 country DUPILUMAB
FMT in IT-refractory HCC - FAB-HCC Pilot Study Ended

2024-516835-29-00 Phase II 1 country ATEZOLIZUMAB; BEVACIZUMAB
Efficacy of Polatuzumab, Bendamustine and Rituximab in patients with relapsed/refractory mantle cell lymphoma Ended

2024-518704-41-00 Phase II 1 country BENDAMUSTINE HYDROCHLORIDE; POLATUZUMAB VEDOTIN; RITUXIMAB
Investigating cardiometabolic risk factors and changes in chronobiology patterns in patients with autonomous adrenal cortisol secretion Ended

2024-512100-19-00 Phase IV 1 country METYRAPONE BP
Albendazole pharmacokinetics in plasma, intra-cystic fluid and cystic tissue of human cystic and alveolar echinococcosis Ended

2024-518548-19-00 Phase I (Other) 1 country
An investigation of heart-lung support without blood thinners during lung transplantation. Ended

2024-519503-10-00 Phase IV 1 country HEPARIN SODIUM; SODIUM CHLORIDE
Personalized dosing of immunosuppression after kidney transplantation by measuring the immune system functionality Ended

2022-500024-30-00 Phase II 6 countries
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-center, Phase III Study to Evaluate the Efficacy and Safety of Baricit… Ended

2024-518556-22-00 Phase III 3 countries BARICITINIB
Pharmacokinetics of antibiotics in cerebrospinal fluid of children with external ventricular drain Ended

2024-515791-12-00 Phase I (Other) 1 country AMPICILLIN SODIUM; CEFAZOLIN; CEFUROXIME SODIUM; GENTAMICIN; LINEZOLID; PIPERACI…

Showing 73–83 of 83 trials

← All sponsors A–Z